Q: Metronidazole neurotoxicity can be diagnosed and can be distinguished when many drugs are concomitantly administered via magnetic resonance imaging (MRI).
A) True
B) False
Answer: A
In metronidazole-induced neurotoxicity, particularly in patients taking higher doses, MRI may show bilateral symmetric T2 hyperintense lesions, and this can be further confirmed by their resolution after stopping the drug. Central metronidazole symptoms are seizures, dizziness, vertigo, ataxia, encephalopathy, irritability, weakness, insomnia, headache, and tremors.
Metronidazole is also commonly associated with peripheral neuropathy, which resolves after cessation of the drug.
#pharmacology
#neurology
#radiology
References:
1. Patel L, Batchala P, Almardawi R, Morales R, Raghavan P. Acute metronidazole-induced neurotoxicity: an update on MRI findings. Clin Radiol. 2020 Mar;75(3):202-208. doi: 10.1016/j.crad.2019.11.002. Epub 2019 Dec 16. PMID: 31858989.
2. Lefkowitz A, Shadowitz S. Reversible cerebellar neurotoxicity induced by metronidazole. CMAJ 2018; 190:E961.
3. Daneman N, Cheng Y, Gomes T, et al. Metronidazole-associated Neurologic Events: A Nested Case-control Study. Clin Infect Dis 2021; 72:2095.